October 22, 2024
TOPLINE: Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients had a 5-year […]
October 22, 2024
TOPLINE: Patients with dry eye disease are more than three times as likely to have mental health conditions, such as depression and anxiety, as those without […]
October 22, 2024
SAVANNAH, Georgia — A new clinical education tool aims to speed the diagnosis of amyotrophic lateral sclerosis (ALS), which often goes undetected for months even in […]
October 22, 2024
TOPLINE: Guselkumab administered every 8 weeks (Q8W) leads to durable improvement in disease activity along with improvements in both skin and joint symptoms over 2 years […]
October 22, 2024
Key Points Data from the Cohort of Cardiovascular Diseases in Pregnancy (CONCEPTION), a French prospective national cohort study, indicate that hypertension before or during pregnancy increases […]
October 22, 2024
How can the immunogenicity and effectiveness of flu vaccines be improved in older adults? Several strategies are available, one being the addition of an adjuvant. For […]
October 22, 2024
(Reuters) – The U.S. Food and Drug Administration has declined to approve Camurus’ drug for the treatment of a rare hormonal disorder due to deficiencies at […]
October 22, 2024
TOPLINE: Treatment with ritlecitinib sustained hair regrowth through week 48 in patients with alopecia areata (AA), and up to one third of nonresponders at week 24 […]
October 22, 2024
In seconds, Ravi Parikh, MD, an oncologist at the Emory University School of Medicine in Atlanta, had a summary of his patient’s entire medical history. Normally, […]